FC
TAK icon

Financial Consulate’s Takeda Pharmaceutical TAK Stock Holding History

Financial Consulate’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.9K Buy
2,640
+1,859
+238% +$32.6K 0.01% 326
2025
Q4 		$12.2K Buy
781
+327
+72% +$4.67K ﹤0.01% 572
2025
Q3 		$6.65K Buy
+454
New +$6.74K ﹤0.01% 612

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Financial Consulate's TAK Position: Q1 2026 in Review

Financial Consulate increased its Takeda Pharmaceutical (TAK) stake by 238% in Q1 2026, buying an estimated $32.6K and bringing the position to 2,640 shares worth $48.9K. The position accounts for 0.01% of the portfolio, ranked #326.

Financial Consulate first reported a position in TAK in Q3 2025 and has held it in 3 quarters since. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Financial Consulate held 2,640 shares of Takeda Pharmaceutical worth $48.9K as of Q1 2026.
  • Financial Consulate bought 1,859 Takeda Pharmaceutical shares in Q1 2026, an estimated $32.6K.
  • Takeda Pharmaceutical made up 0.01% of Financial Consulate's portfolio in Q1 2026, its #326 holding.
  • Financial Consulate first reported a position in Takeda Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.